Similarly to mouse AP-2 mutants and human patients with Char syndrome, Drosophila AP-2 mutants are defective in joint development, where AP-2 acts in regulatory pathways that coordinate limb-growth with development of local and higher order aspects of limb-specific neural circuitry [18, 19]. This evidence concerns the gene TFAP2A and Char syndrome.